Device Trial Radar · NCT04289051
Clinical Evaluation of Oral Rinse for Xerostomia
Last checked: Nov 20, 2026Latest source record: Feb 24, 2022 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
39
Actual
Start
Aug 19, 2020
Primary completion
Feb 4, 2021
Study completion Feb 4, 2021
Sponsor
- Lead sponsor
- Sunstar AmericasNot on our public-company list
- Sponsor type
- Industry
- First posted
- Feb 28, 2020
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Randomized
- Model
- Crossover
- Masking
- Double (participant, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated device
- Yes
- Who can join
- All sexes, from 18 years, up to 80 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
Xerostomia causes a difficulty in eating, have irritated oral tissues, and a poor quality of life. The new oral rinse was designed to reduce the symptoms and improve the patient's quality of life. The objectives of the clinical study is to evaluate the effectiveness of the oral rinse comparing to the placebo product and the control product in the market. This is a randomized double-blind placebo controlled crossover study with 39 patients receiving treatment. Patients will be randomly allocated to three treatment groups. Patients will use the assigned oral rinse four times a day for two weeks. Dry mouth symptoms and other endpoints will be assessed subjectively and objectively at baseline and Day 14. Patients will be assigned to another treatment after one week wash-out period.
Conditions
- Xerostomia
Interventions
HYDRAL Oral RinseDevice
Application 4 times a day for two weeks
BIOTENE® Oral RinseDevice
Application 4 times a day for two weeks
Placebo Oral RinseDevice
Application 4 times a day for two weeks
Primary outcomes
What the sponsor says the trial is designed to measure.
- Change in Dry Mouth Symptom by Visual Analog Scale at 14 Days From BaselineTime frame: Baseline, 14 days
- Change in Dry Mouth Symptoms by Xerostomia Questionnaire at 14 Days From BaselineTime frame: Baseline, 14 days
Locations
1 site in 1 country. Site status is shown where the registry gives one.
University at Buffalo, The Center for Dental Studies
Buffalo, New York
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.